Delivery Order SPE2DE24DA010-SPE2D626F69P1
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,495 on December 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority has a performance completion date of January 6, 2026, and will be performed in Santa Clara, California. The award carries no set-aside designation and was made through full and open competition, consistent with Abbott Vascular's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $21,147 fixed-price delivery order (Contract 4570006266, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. The delivery order, issued without any small business set-aside, is for performance at Abbott's Santa Clara, California location. This award represents a task order under Abbott's established relationship with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $5,495.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025. This child contract is a delivery order with an ultimate completion date of January 6, 2026, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, reflecting Abbott's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $37,164.80 by the Medical Supply Chain division of the Department of Defense on June 18, 2025, with a completion date of June 24, 2025. The award is designated as a fixed-price contract with economic price adjustment and was issued without a set-aside, indicating full and open competition. Performance will be executed at Abbott's facility in Santa Clara, California. This delivery order...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F69P1Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract (4570382323 GALLANT) valued at $25,875.85 on December 11, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price contract with economic price adjustment terms is scheduled for completion by January 6, 2026, and will be performed in Santa Clara, California. The contract utilizes no set-aside designation and was awarded through full and open competition, reflecting Abbott's established competitive position as a federal healthcare supplier. This delivery order represents a continuation of Abbott Vascular's strategic role as a critical supplier of cardiovascular medical technologies to federal healthcare systems. Abbott Vascular maintains a substantial $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency that encompasses comprehensive cardiovascular procedural packages, including devices, instrumentation, accessories, and related medical technologies. The company's federal contracting portfolio demonstrates consistent success in providing advanced cardiovascular solutions—including stents, pacemakers, heart valves, implantable cardiac monitors, and left ventricular assist devices—to the Department of Veterans Affairs and Department of Defense across multiple healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 12/10/25 |